Retreatment with injectable poly-L-lactic acid for HIV-associated facial lipoatrophy: 24-Month extension of the blue pacific study

Dermatologic Surgery

Volumn 35, Issue SUPPL. 1, 2009, Pages 350-359

  Mest, Douglas R ^a   Humble, Gail M ^a  

^a Blue Pacific Aesthetic Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYLACTIC ACID;

ADULT; AGED; ARTICLE; FACIAL LIPOATROPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; INJECTION SITE SWELLING; JAMES SCALE; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; PAPULE; PATIENT; PATIENT SATISFACTION; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RETREATMENT; SAFETY; SKINFOLD THICKNESS;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INJECTIONS, INTRADERMAL; LACTIC ACID; MALE; MIDDLE AGED; PATIENT SATISFACTION; POLYMERS; PROSTHESES AND IMPLANTS; RETREATMENT;

EID: 59349093072     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.01047.x     Document Type: Article

References (18)

1. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-l-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005 52 : 233 9.
2. Moyle GJ, Brown S, Lysakova L, et al. Long-term safety and efficacy of poly-l-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med 2006 7 : 181 5.
3. Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read 2000 10 : 546 1.
4. Carrieri P, Cailleton V, Le MV, et al. The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr 2001 28 : 232 9.
5. Power R, Tate HL, McGill SM, et al. A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sex Transm Infect 2003 79 : 137 41.
6. Martínez E, Garcia-Viejo MA, Blanch L, et al. Lipodystrophy syndrome in patients with HIV infection: quality of life issues. Drug Saf 2001 24 : 157 66.
7. Duran S, Savès M, Spire B, et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS 2001 15 : 2441 4.
8. Vleggaar D. Facial volumetric correction with injectable poly-l-lactic acid. Dermatol Surg 2005 31 : 1511 8.
9. Woerle B, Hanke CW, Sattler G. Poly-l-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 2004 3 : 385 9.
10. Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004 5 : 82 7.
11. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 2003 17 : 2471 7.
12. Cattelan AM, Bauer U, Trevenzoli M, et al. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy. Arch Dermatol 2006 142 : 329 34.
13. Mest DR, Humble G. Safety and efficacy of poly-l-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg 2006 32 : 1336 45.
14. Sculptra [prescribing information]. Berwyn, PA; Dermik Laboratories; 2006.
15. Vleggaar D. Poly-l-lactic acid: consultation on the injection techniques. J Eur Acad Dermatol Venereol 2006 20 (suppl 1) : 17 21.
16. Lafaurie M, Dolivo M, Porcher R, et al. Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients. J Acquir Immune Defic Syndr 2005 38 : 393 8.
17. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet Plast Surg 2003 27 : 354 66.
18. James J, Carruthers A, Carruthers J. HIV-associated facial lipoatrophy. Dermatol Surg 2002 28 : 979 86.